Wednesday, 08 February 2017 08:12

Recall Of Three Lots Of Fentanyl Citrate Injection

Rate this item
(77 votes)

The attention of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to the recall of three lots of Fentanyl Citrate Injection, 50mcg/mL over confirmed ampoules with broken tips.

Fentanyl is a potent, synthetic opioid pain medication with a rapid onset and short duration of action. It is a potent agonist at the μ-opioid receptors. Fentanyl Citrate Injection is indicated as short-term analgesia during anaesthetic periods, premedication, induction and maintenance and as an analgesic supplement in general or regional anaesthesia. Fentanyl Citrate is used for intravenous (IV) or intramuscular (IM) use.

PRODUCT DETAILS: 

  • NAME- Fentanyl Citrate Injection 50mcg/mL

# Affected Lot Numbers:  59277EV, 60028EV

  • EXPIRY DATES- 1st November 2017, 1st December 2017.

 

HEALTHCARE PROVIDER’S ACTION

  • Healthcare providers should provide adequate warnings to stop using the affected products.
  • Healthcare providers and patients are encouraged to report adverse events associated with the use of these products to the nearest NAFDAC office, NAFDAC PRASCOR (20543 TOLL FREE from all networks) or via This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC.........Safeguarding the Health of the Nation!!!

Read 7570 times Last modified on Wednesday, 08 February 2017 08:24

CORPORATE LINKS